Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1997 Oct;63(4):468–473. doi: 10.1136/jnnp.63.4.468

Effects of antipsychotic medication on electromyographic responses to transcranial magnetic stimulation of the motor cortex in schizophrenia

N Davey 1, B Puri 1, H Lewis 1, S Lewis 1, P Ellaway 1
PMCID: PMC2169776  PMID: 9343125

Abstract

OBJECTIVE—To assess the effect of antidopaminergic antipsychotic medication on the electromyographic (EMG) responses of thenar muscles to transcranial magnetic stimulation (TMS) of the motor cortex in schizophrenic patients.
METHODS—A group of nine drug naïve schizophrenic patients was compared with a group of nine schizophrenic patients established on neuroleptic medication. Surface EMG recordings were made from the thenar muscles while patients maintained a weak isometric voluntary contraction. TMS was applied using a 9 cm circular stimulating coil centred over the vertex. The EMG responses to up to 50 magnetic stimuli were rectified and averaged.
RESULTS—There was no difference in threshold TMS strength for eliciting compound motor evoked potentials (cMEPs), or in their latency, in drug naïve and medicated patients. In some patients the silent period (SP) was clearly made up of two parts and the percentage of control levels of voluntary EMG was measured in each component. During the early component of the SP there was a weaker (P<0.05) suppression of EMG in the medicated patients (mean 73.9 (SEM) 5.5% of control levels) compared with the drug naïve patients (54.7 (SEM) 7.3% of control levels). This resulted in the latency of maximum suppression of voluntary EMG being longer (P<0.05) in the medicated patients (38.3 (2.4) ms) than in the drug naïve patients (28.2 (0.7) ms). During the late component of the SP voluntary EMG was reduced to similar levels (P>0.05) in both medicated (48.2 (7.7)% of control levels) and drug naïve (58 (7.8)% of control levels) patients.
CONCLUSION—The results are discussed with reference to the disrupted inhibition seen in the early part of the SP in Parkinson's disease and drug induced parkinsonism. The future uses of motor responses to TMS as a marker for the status of antipsychotic medication are considered.



Full Text

The Full Text of this article is available as a PDF (127.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker A. T., Jalinous R., Freeston I. L. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985 May 11;1(8437):1106–1107. doi: 10.1016/s0140-6736(85)92413-4. [DOI] [PubMed] [Google Scholar]
  2. Baruch I., Hemsley D. R., Gray J. A. Differential performance of acute and chronic schizophrenics in a latent inhibition task. J Nerv Ment Dis. 1988 Oct;176(10):598–606. doi: 10.1097/00005053-198810000-00004. [DOI] [PubMed] [Google Scholar]
  3. CARLSSON A., LINDQVIST M. EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. Acta Pharmacol Toxicol (Copenh) 1963;20:140–144. doi: 10.1111/j.1600-0773.1963.tb01730.x. [DOI] [PubMed] [Google Scholar]
  4. Creese I., Burt D. R., Snyder S. H. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science. 1976 Apr 30;192(4238):481–483. doi: 10.1126/science.3854. [DOI] [PubMed] [Google Scholar]
  5. Davey N. J., Romaiguère P., Maskill D. W., Ellaway P. H. Suppression of voluntary motor activity revealed using transcranial magnetic stimulation of the motor cortex in man. J Physiol. 1994 Jun 1;477(Pt 2):223–235. doi: 10.1113/jphysiol.1994.sp020186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ellaway P. H. Cumulative sum technique and its application to the analysis of peristimulus time histograms. Electroencephalogr Clin Neurophysiol. 1978 Aug;45(2):302–304. doi: 10.1016/0013-4694(78)90017-2. [DOI] [PubMed] [Google Scholar]
  7. Ferbert A., Priori A., Rothwell J. C., Day B. L., Colebatch J. G., Marsden C. D. Interhemispheric inhibition of the human motor cortex. J Physiol. 1992;453:525–546. doi: 10.1113/jphysiol.1992.sp019243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Haug B. A., Schönle P. W., Knobloch C., Köhne M. Silent period measurement revives as a valuable diagnostic tool with transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol. 1992 Apr;85(2):158–160. doi: 10.1016/0168-5597(92)90081-l. [DOI] [PubMed] [Google Scholar]
  9. Jones E. G. Varieties and distribution of non-pyramidal cells in the somatic sensory cortex of the squirrel monkey. J Comp Neurol. 1975 Mar 15;160(2):205–267. doi: 10.1002/cne.901600204. [DOI] [PubMed] [Google Scholar]
  10. Pickar D., Labarca R., Linnoila M., Roy A., Hommer D., Everett D., Paul S. M. Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients. Science. 1984 Aug 31;225(4665):954–957. doi: 10.1126/science.6474162. [DOI] [PubMed] [Google Scholar]
  11. Priori A., Berardelli A., Inghilleri M., Accornero N., Manfredi M. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain. 1994 Apr;117(Pt 2):317–323. doi: 10.1093/brain/117.2.317. [DOI] [PubMed] [Google Scholar]
  12. Puri B. K., Davey N. J., Ellaway P. H., Lewis S. W. An investigation of motor function in schizophrenia using transcranial magnetic stimulation of the motor cortex. Br J Psychiatry. 1996 Dec;169(6):690–695. doi: 10.1192/bjp.169.6.690. [DOI] [PubMed] [Google Scholar]
  13. Ridding M. C., Inzelberg R., Rothwell J. C. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol. 1995 Feb;37(2):181–188. doi: 10.1002/ana.410370208. [DOI] [PubMed] [Google Scholar]
  14. Rothwell J. C., Thompson P. D., Day B. L., Boyd S., Marsden C. D. Stimulation of the human motor cortex through the scalp. Exp Physiol. 1991 Mar;76(2):159–200. doi: 10.1113/expphysiol.1991.sp003485. [DOI] [PubMed] [Google Scholar]
  15. Seeman P., Lee T., Chau-Wong M., Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature. 1976 Jun 24;261(5562):717–719. doi: 10.1038/261717a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES